(Journal Article): Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhi-bitory polypeptide in patients with type-2 diabetes mellitus.
 
Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W
 
IN: J Clin Invest 1993; 91:301-307
Impact Factor(s) of J Clin Invest: 14.204 (2004), 14.307 (2003), 14.118 (2001)

ABSTRACT: In type-2 diabetes, the overall incretin effect is reduced. The present investigation was designed to compare insulinotropic actions of exogenous incretin hormones (gastric inhibit... Click HERE for details